vs
Side-by-side financial comparison of AbbVie (ABBV) and Oracle Corporation (ORCL). Click either name above to swap in a different company.
Oracle Corporation is the larger business by last-quarter revenue ($16.1B vs $15.0B, roughly 1.1× AbbVie). Oracle Corporation runs the higher net margin — 38.2% vs 4.6%, a 33.6% gap on every dollar of revenue. On growth, Oracle Corporation posted the faster year-over-year revenue change (14.2% vs 9.9%). Over the past eight quarters, Oracle Corporation's revenue compounded faster (10.0% CAGR vs 1.8%).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
An oracle is a person or thing considered to provide insight, wise counsel or prophetic predictions, most notably including precognition of the future, inspired by deities. If done through occultic means, it is a form of divination.
ABBV vs ORCL — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $15.0B | $16.1B |
| Net Profit | $697.0M | $6.1B |
| Gross Margin | — | — |
| Operating Margin | 26.6% | 29.5% |
| Net Margin | 4.6% | 38.2% |
| Revenue YoY | 9.9% | 14.2% |
| Net Profit YoY | -45.9% | 94.7% |
| EPS (diluted) | $0.39 | $2.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $15.0B | — | ||
| Q4 25 | $16.6B | $16.1B | ||
| Q3 25 | $15.8B | $14.9B | ||
| Q2 25 | $15.4B | $15.9B | ||
| Q1 25 | $13.3B | $14.1B | ||
| Q4 24 | $15.1B | $14.1B | ||
| Q3 24 | $14.5B | $13.3B | ||
| Q2 24 | $14.5B | $14.3B |
| Q1 26 | $697.0M | — | ||
| Q4 25 | $1.8B | $6.1B | ||
| Q3 25 | $186.0M | $2.9B | ||
| Q2 25 | $938.0M | $3.4B | ||
| Q1 25 | $1.3B | $2.9B | ||
| Q4 24 | $-22.0M | $3.2B | ||
| Q3 24 | $1.6B | $2.9B | ||
| Q2 24 | $1.4B | $3.1B |
| Q1 26 | — | — | ||
| Q4 25 | 72.6% | — | ||
| Q3 25 | 66.4% | — | ||
| Q2 25 | 71.8% | — | ||
| Q1 25 | 70.0% | — | ||
| Q4 24 | 70.9% | — | ||
| Q3 24 | 70.9% | — | ||
| Q2 24 | 70.9% | — |
| Q1 26 | 26.6% | — | ||
| Q4 25 | 27.3% | 29.5% | ||
| Q3 25 | 12.1% | 28.7% | ||
| Q2 25 | 31.7% | 32.1% | ||
| Q1 25 | 28.0% | 30.8% | ||
| Q4 24 | -9.9% | 30.0% | ||
| Q3 24 | 26.5% | 30.0% | ||
| Q2 24 | 27.6% | 32.8% |
| Q1 26 | 4.6% | — | ||
| Q4 25 | 10.9% | 38.2% | ||
| Q3 25 | 1.2% | 19.6% | ||
| Q2 25 | 6.1% | 21.5% | ||
| Q1 25 | 9.6% | 20.8% | ||
| Q4 24 | -0.1% | 22.4% | ||
| Q3 24 | 10.8% | 22.0% | ||
| Q2 24 | 9.5% | 22.0% |
| Q1 26 | $0.39 | — | ||
| Q4 25 | $1.02 | $2.10 | ||
| Q3 25 | $0.10 | $1.01 | ||
| Q2 25 | $0.52 | $1.19 | ||
| Q1 25 | $0.72 | $1.02 | ||
| Q4 24 | $-0.03 | $1.10 | ||
| Q3 24 | $0.88 | $1.03 | ||
| Q2 24 | $0.77 | $1.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $19.2B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $30.0B |
| Total Assets | — | $205.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $5.3B | $19.2B | ||
| Q3 25 | $5.7B | $10.4B | ||
| Q2 25 | $6.5B | $10.8B | ||
| Q1 25 | $5.2B | $17.4B | ||
| Q4 24 | $5.6B | $10.9B | ||
| Q3 24 | $7.3B | $10.6B | ||
| Q2 24 | $13.2B | $10.5B |
| Q1 26 | — | — | ||
| Q4 25 | $58.9B | — | ||
| Q3 25 | $63.0B | — | ||
| Q2 25 | $63.0B | — | ||
| Q1 25 | $64.5B | — | ||
| Q4 24 | $60.3B | — | ||
| Q3 24 | $58.5B | — | ||
| Q2 24 | $58.0B | — |
| Q1 26 | — | — | ||
| Q4 25 | $-3.3B | $30.0B | ||
| Q3 25 | $-2.6B | $24.2B | ||
| Q2 25 | $-183.0M | $20.5B | ||
| Q1 25 | $1.4B | $16.7B | ||
| Q4 24 | $3.3B | $13.7B | ||
| Q3 24 | $6.0B | $10.8B | ||
| Q2 24 | $6.8B | $8.7B |
| Q1 26 | — | — | ||
| Q4 25 | $134.0B | $205.0B | ||
| Q3 25 | $133.9B | $180.4B | ||
| Q2 25 | $137.2B | $168.4B | ||
| Q1 25 | $136.2B | $161.4B | ||
| Q4 24 | $135.2B | $148.5B | ||
| Q3 24 | $143.4B | $144.2B | ||
| Q2 24 | $141.9B | $141.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 45.44× | — | ||
| Q4 24 | 18.15× | — | ||
| Q3 24 | 9.70× | — | ||
| Q2 24 | 8.56× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $2.1B |
| Free Cash FlowOCF − Capex | — | $-10.0B |
| FCF MarginFCF / Revenue | — | -62.1% |
| Capex IntensityCapex / Revenue | — | 74.9% |
| Cash ConversionOCF / Net Profit | — | 0.34× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-13.2B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $5.2B | $2.1B | ||
| Q3 25 | $7.0B | $8.1B | ||
| Q2 25 | $5.2B | $6.2B | ||
| Q1 25 | $1.6B | $5.9B | ||
| Q4 24 | $7.0B | $1.3B | ||
| Q3 24 | $5.4B | $7.4B | ||
| Q2 24 | $2.3B | $6.1B |
| Q1 26 | — | — | ||
| Q4 25 | $4.9B | $-10.0B | ||
| Q3 25 | $6.6B | $-362.0M | ||
| Q2 25 | $4.9B | $-2.9B | ||
| Q1 25 | $1.4B | $71.0M | ||
| Q4 24 | $6.8B | $-2.7B | ||
| Q3 24 | $5.2B | $5.1B | ||
| Q2 24 | $2.0B | $3.3B |
| Q1 26 | — | — | ||
| Q4 25 | 29.4% | -62.1% | ||
| Q3 25 | 42.1% | -2.4% | ||
| Q2 25 | 31.7% | -18.4% | ||
| Q1 25 | 10.5% | 0.5% | ||
| Q4 24 | 44.7% | -19.0% | ||
| Q3 24 | 35.9% | 38.5% | ||
| Q2 24 | 14.0% | 23.0% |
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | 74.9% | ||
| Q3 25 | 2.4% | 57.0% | ||
| Q2 25 | 1.7% | 57.1% | ||
| Q1 25 | 1.8% | 41.5% | ||
| Q4 24 | 1.9% | 28.2% | ||
| Q3 24 | 1.7% | 17.3% | ||
| Q2 24 | 1.7% | 19.6% |
| Q1 26 | — | — | ||
| Q4 25 | 2.87× | 0.34× | ||
| Q3 25 | 37.76× | 2.78× | ||
| Q2 25 | 5.49× | 1.80× | ||
| Q1 25 | 1.27× | 2.02× | ||
| Q4 24 | — | 0.41× | ||
| Q3 24 | 3.49× | 2.54× | ||
| Q2 24 | 1.66× | 1.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABBV
Segment breakdown not available.
ORCL
| Software Support | $4.9B | 31% |
| Cloud Infrastructure | $4.1B | 25% |
| Cloud Applications | $3.9B | 24% |
| Services Business | $1.4B | 9% |
| Software License | $939.0M | 6% |
| Hardware Business | $776.0M | 5% |
